Sign in

CIK 0001453687

  • Non-accelerated filer
  • Smaller reporting company

Cartesian Therapeutics, Inc.

Sign in to watch
Ticker
RNAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-348-8698
Business address
7495 NEW HORIZON WAY, FREDERICK, MD, 21703
Former names
SELECTA BIOSCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-06-01 Brunn Carsten President and CEO Option exercise · Restricted Stock Units −10,938 21,875
2022-05-09 BARABE TIMOTHY C Director Purchase +50,000 $0.77 $39K 250,013
2022-04-11 SPRINGER TIMOTHY A Director Purchase +6,681,600 29,868,490
2022-04-11 SPRINGER TIMOTHY A Director Grant or award · Warrant (right to buy) +5,011,200 5,011,200
2022-03-02 Brunn Carsten President and CEO Sale −5,443 $1.81 $10K 523,452
2022-03-01 Brunn Carsten President and CEO Option exercise +10,937 528,895
2022-03-01 Brunn Carsten President and CEO Option exercise · Restricted Stock Units −10,937 32,813
2022-01-14 BARABE TIMOTHY C Director Option exercise +10,000 $2.10 $21K 200,013
2022-01-14 BARABE TIMOTHY C Director Option exercise · Stock Option (Right to Buy) −10,000 $2.10 $21K 0
2022-01-05 TRABER PETER G Chief Medical Officer Sale −3,226 $3.09 $10K 251,355
2022-01-05 Kishimoto Takashi Kei Chief Scientific Officer Sale −3,416 $3.09 $11K 268,353
2022-01-05 Johnston Lloyd P. Chief Operations Officer Sale −3,416 $3.09 $11K 175,299
2022-01-05 Brunn Carsten President and CEO Sale −13,597 $3.09 $42K 517,958
2022-01-03 ZENNER PATRICK J Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2022-01-03 TRABER PETER G Chief Medical Officer Grant or award +90,200 254,581
2022-01-03 TRABER PETER G Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +415,900 415,900
2022-01-03 Tan Kevin Chief Financial Officer Grant or award +72,000 77,000
2022-01-03 Tan Kevin Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +340,000 340,000
2022-01-03 SPRINGER TIMOTHY A Director Grant or award · Stock Option (Right to Buy) +40,000 40,000
2022-01-03 Sallin Aymeric Director Grant or award · Stock Option (Right to Buy) +40,000 40,000

Page 21 of 25 · 495 trades